Market Cap : 153.99 B | Enterprise Value : 183.77 B | PE Ratio : 23.96 | PB Ratio : 4.72 |
---|
NYSE:BMY has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NYSE:BMY has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
This is the average share buyback rate of the company over the past 3 years. A negative number means the company might be issuing new shares. A positive number indicates that the company is buying back shares.
The historical rank and industry rank for Bristol-Myers Squibb Co's 3-Year Average Share Buyback Ratio or its related term are showing as below:
During the past years, Bristol-Myers Squibb Co's highest 3-Year Average Share Buyback Ratio was 5.20. The lowest was -11.00. And the median was 0.60.
BMY's 3-Year Average Share Buyback Ratio is ranked worse thanThe historical data trend for Bristol-Myers Squibb Co's 3-Year Average Share Buyback Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - General subindustry, Bristol-Myers Squibb Co's 3-Year Average Share Buyback Ratio, along with its competitors' market caps and 3-Year Average Share Buyback Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Drug Manufacturers industry and Healthcare sector, Bristol-Myers Squibb Co's 3-Year Average Share Buyback Ratio distribution charts can be found below:
* The bar in red indicates where Bristol-Myers Squibb Co's 3-Year Average Share Buyback Ratio falls into.
This is the average share buyback rate of the company over the past 3 years.
A negative number means the company might be issuing new shares. A positive number indicates that the company is buying back shares.
Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.
Thank you for viewing the detailed overview of Bristol-Myers Squibb Co's 3-Year Average Share Buyback Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Greenlees Sharon | officer: SVP & Controller | BRISTOL MYERS SQUIBB ROUTE 206 & PROVINCE LINE ROAD PRINCETON NJ 08543 |
Shanahan Karin | officer: EVP, Glob. Prod. Dev. & Supply | BRISTOL MYERS SQUIBB ROUTE 206 & PROVINCE LINE ROAD PRINCETON NJ 08543 |
Meyers Gregory Scott | officer: EVP, Chief Digital & Tech Off. | BRISTOL MYERS SQUIBB ROUTE 206 & PROVINCE LINE ROAD PRINCETON NJ 08543 |
Weese Michelle | officer: EVP, Corporate Affairs | BRISTOL MYERS SQUIBB ROUTE 206 & PROVINCE LINE ROAD PRINCETON NJ 08543 |
Hidalgo Medina Manuel | director | BRISTOL MYERS SQUIBB 430 E. 29TH STREET, 14TH FLOOR NEW YORK NY 10016 |
Rice Derica W | director | 1000 NICOLLET MALL TPS-3155 MINNEAPOLIS MN 55403 |
Price Paula A | director | ONE CVS DRIVE WOONSOCKET RI 02895 |
Mily Elizabeth | officer: EVP, Strategy & BD | BRISTOL-MYERS SQUIBB COMPANY ROUTE 206 & PROVENCE LINE ROAD PRINCETON NJ 08540 |
Metcalfe Kathryn | officer: EVP, Corporate Affairs | BRISTOL-MYERS SQUIBB COMPANY ROUTE 206 & PROVINCE LINE ROAD PRINCETON NJ 08543 |
Vessey Rupert | officer: Pres., Research & Early Dev. | C/O CELGENE CORPORATION 86 MORRIS AVENUE SUMMIT NJ 07901 |
Elkins David V | officer: EVP, Chief Financial Officer | C/O BECTON, DICKINSON AND COMPANY 1 BECTON DRIVE FRANKLIN LAKES NJ 07417 |
Bonney Michael W | director | 65 HAYDEN AVE LEXINGTON MA 02421 |
Yale Phyllis R | director | |
Ahmed Nadim | officer: President, Hematology | C/O CELGENE CORPORATION 86 MORRIS AVENUE SUMMIT NJ 07901 |
Haller Julia A | director | C/O CELGENE CORPORATION 86 MORRIS AVENUE SUMMIT NJ 07901 |
From GuruFocus
Other Sources
By Zacks 2022-03-29
By Zacks 2022-03-28
By Zacks 2022-03-25
By Zacks 2022-03-30
By Zacks 2022-03-23
By Fool 2022-03-31
By Zacks 2022-04-05
By Zacks 2022-03-30
By Fool 2022-03-30
By Zacks 2022-03-15
By Zacks 2022-04-05
By Fool 2022-04-05
By Zacks 2022-03-21